CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 4 Planned sale President sold 4,000 shares at an average $12.64 ($50,553)
- 4 Planned sale President sold 4,000 shares at an average $12.10 ($48,399)
- 4 Planned sale President sold 4,000 shares at an average $10.86 ($43,440)
- 4 Planned sale President sold 4,000 shares at an average $11.21 ($44,852)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 3,452 shares at $12.00 ($41,438)
- 4 Planned sale Director sold 20,000 shares at an average $14.13 ($282,577)
- 4 Planned sale Director sold 20,000 shares at $16.15 ($323,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 5 of 37 · 739 filings